Viewing StudyNCT00436826



Ignite Creation Date: 2024-05-05 @ 5:20 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00436826
Status: COMPLETED
Last Update Posted: 2020-10-12
First Post: 2007-02-15

Brief Title: A Phase 2 Study of Cladribine Add-on to Interferon-beta IFN-beta Therapy in Multiple Sclerosis MS Subjects With Active Disease ONWARD
Sponsor:
Organization: EMD Serono

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 172
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: